Last reviewed · How we verify
DTRMWXHS-12
At a glance
| Generic name | DTRMWXHS-12 |
|---|---|
| Sponsor | Zhejiang DTRM Biopharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DTRMWXHS-12 CI brief — competitive landscape report
- DTRMWXHS-12 updates RSS · CI watch RSS
- Zhejiang DTRM Biopharma portfolio CI